by EmVenio | Feb 27, 2023 | Blog
The SCOPE 2023 Summit was a major success, with attendees from all over the world gathering to learn more about the latest developments in the clinical trial industry. The event was full of memorable moments, from keynotes, workshops, and demos to the SCOPE 2023 Best...
by EmVenio | Feb 21, 2023 | Press Release
DURHAM, N.C., Feb. 21, 2023 /PRNewswire/ — EmVenio Research activated a mobile community research site in Claremont, California, as part of a concerted effort to maximize diversity, equity and inclusion in research studies and deliver...
by EmVenio | Feb 16, 2023 | Press Release
DURHAM, N.C., Feb. 16, 2023 – In an effort to maximize diversity, equity and inclusion in clinical research, EmVenio Research activated 10 community research sites among diverse populations across the United States. This concerted effort marks the value EmVenio’s...
by EmVenio | Feb 15, 2023 | Press Release
Mobile Community Clinical Research Facility to be Deployed in California Atlanta, GA, February 15, 2023 – GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company developing immunotherapies and vaccines against cancers and infectious diseases, and EmVenio Research, a...
by EmVenio | Sep 15, 2022 | Press Release
Agreement signed for Ripple Enterprise patient engagement software to be deployed by EmVenio Research, making decentralized trials rapid and scalable. ANN ARBOR, MI, AND DURHAM, NC, USA, September 15, 2022 /EINPresswire.com/ — Ripple Science, a digital clinical...
